Predicting coronary heart disease in renal transplant recipients: A prospective study

Ducloux, Didier; Kazory, Amir; Chalopin, Jean-Marc
July 2004
Kidney International;Jul2004, Vol. 66 Issue 1, p441
Academic Journal
Predicting coronary heart disease in renal transplant recipients: A prospective study. Background. Current cardiovascular risk calculators, widely used in the general population, have not yet been validated in renal transplant recipients. We conducted a prospective study to determine the incidence and risk factors for ischemic heart disease in renal transplant recipients and to assess the relevance of the Framingham Heart Study risk calculator in this population. Methods. Three hundred and forty four consecutive renal transplant recipients free of vascular disease were enrolled. Coronary events were registered and analyzed with respect to traditional and nontraditional cardiovascular risk factors. The risk of coronary events was assessed through the Framingham Heart Study formula and the relevance of this equation was then analyzed. Results. The patients were followed for a mean duration of 72 ± 14 months. Twenty seven coronary events occurred in 27 patients (7.8%). In addition to risk factors included in the Framingham Heart Study score, C-reactive protein (CRP) level ( P= 0.009), and hyperhomocysteinemia ( P= 0.01) were found to be independent risk factors for ischemic heart disease events in renal transplant recipients. The Framingham Heart Study model did not predict absolute ischemic heart disease risk in the transplant population as a whole. Conclusion. Nontraditional cardiovascular risk factors greatly contribute to increased incidence of ischemic heart disease events in renal transplant recipients. They should therefore be considered in preventive care of these patients which relies on reduction of overall absolute risk. Although the Framingham Heart Study score has an excellent predictive value in low-risk renal transplant recipients, it tends to underestimate the real cardiovascular risk in high-risk patients.


Related Articles

  • The inherited real risk of coronary artery disease. Stagnaro, S; Caramel, S // European Journal of Clinical Nutrition;Jun2013, Vol. 67 Issue 6, p683 

    No abstract available.

  • Inflammation in ischaemic heart disease. Maseri, Attilio; Biasucci, Luigi M.; Liuzzo, Giovanna // BMJ: British Medical Journal (International Edition);4/27/96, Vol. 312 Issue 7038, p1049 

    Editorial. Comments on the results of the study conducted by Mendall et al. from London, England showing the relation between C reactive protein concentrations and the risk factors for ischemic heart disease. Effects of the increase in C reactive protein concentrations; Useful information...

  • Coronary Lesions Complexity in Patients With Stable Coronary Artery Disease. Unlu, Murat; Balta, Sevket; Cakar, Mustafa; Demirkol, Sait; Arslan, Zekeriya; Sarlak, Hakan // Angiology;May2013, Vol. 64 Issue 4, p310 

    A letter to the editor is presented in response to the article ``Predictors of Coronary Lesions Complexity in Patients with Stable Coronary Artery Disease'' by Aksakal and colleagues in the November 2012 issue.

  • Serum hsCRP: A Novel Marker for Prediction of Cerebrovascular Accidents (Stroke). PATGIRI, DIBYARATNA; SAIKIA PATHAK, MAUCHUMI; SHARMA, PRADEEP; KUTUM, TRIDIP; MATTACK, NIRMALI // Journal of Clinical & Diagnostic Research;Dec2014, Vol. 8 Issue 12, p8 

    Introduction and Objectives: Strokes are caused by disruption of the blood supply to the brain. This may result from either blockage or rupture of a blood vessel. Yearly 15 million people worldwide suffer a stroke. India ranks second worldwide in terms of deaths from stroke. The incidence of...

  • Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease. Grandi, Norma Christine; Breitling, Lutz Philipp; Hahmann, Harry; Wüsten, Bernd; Miärz, Winfred; Rothenbacher, Dietrich; Brenner, Hermann // Heart;Aug2011, Vol. 97 Issue 15, p1215 

    Background and objective Recent longitudinal studies have suggested an association of high serum parathyroid hormone levels (PTH) with elevated cardiovascular risk in the general population. This study presents analyses of the prognostic value of baseline PTH for subsequent cardiovascular events...

  • DISTRIBUTION OF VASCULAR RISK FACTORS IN BRAÅžOV STROKE REGISTRY. MOARCĂŞ, M.; BUSTAN, M.; MIRCEA, R.; TECĂU, M.; FALUP-PECURARIU, O.; CHIPERI, R.; MONESCU, V.; FALUP-PECURARIU, C. // Bulletin of the Transilvania University of Brasov, Seriels VI: M;2013, Vol. 6 Issue 1, p23 

    As stroke remains one of the main causes of mortality worldwide, knowing the risk factors for stroke facilitates the implementation of prevention programs. We studied the distribution of risk factors for stroke in the population included in Brasov Stroke Registry. We included 119 cases in the...

  • Effects of Ezetimibe on Endothelial Progenitor Cells and Microparticles in High-Risk Patients. Lins, Lívia; França, Carolina; Fonseca, Francisco; Barbosa, Simone; Matos, Lívia; Aguirre, Ana; Bianco, Henrique; Amaral, Jonatas; Izar, Maria // Cell Biochemistry & Biophysics;Sep2014, Vol. 70 Issue 1, p687 

    Imbalance on endothelial turnover can predict cardiovascular outcomes. We aimed at evaluating the effects of lipid-modifying therapies on circulating endothelial progenitor cells (EPCs), endothelial microparticles (EMPs), and platelet microparticles (PMPs) in high cardiovascular risk subjects...

  • Cardiovascular risk and rheumatoid arthritis—the next step: differentiating true soluble biomarkers of cardiovascular risk from surrogate measures of inflammation. Kozera, Lukasz; Andrews, Jacqueline; Morgan, Ann W. // Rheumatology;Nov2011, Vol. 50 Issue 11, p1944 

    In the past decade, there has been a surge of interest in the examination of cardiovascular (CV) outcomes in RA, where it is widely accepted that there is an enhanced risk of CV disease (CVD). In recent years, a number of novel soluble biomarkers of CV risk have been examined in the general...

  • Subclinical Hypothyroidism is not Associated with Hyperhomocysteinyemia. Sahin, Mustafa; Dogruk, Asli; Kulaksizoglu, Mustafa; G�rsoy, Alptekin; Ertugrul, Derun; Bozkirli, Emre; Yilmaz, Hamiyet; T�t�nc�, Neslihan B.; G�vener, Nilg�n D. // Turkish Journal of Endocrinology & Metabolism;2008, Vol. 12 Issue 2, p42 

    Objective: There are controversial reports regarding subclinical hypothyroidism and its association with hyperhomocysteinyemia. We aimed to evaluate whether subclinical hypothyroidism is associated with hyperhomocysteinyemia and sought to explain the observed increased risk of coronary artery...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics